BENJAMIN MASTRIDGE: Open Payments
NPI 1942421508 · YOUNGSVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,942 in 100 payments from 15 companies in 2025. Trend: 2023 $1,442 · 2024 $1,659 · 2025 $1,942
Food & beverage: $1,915Education: $27
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 17 | $441 |
| Teva Pharmaceuticals USA, Inc. | 19 | $300 |
| Janssen Pharmaceuticals, Inc | 11 | $281 |
| ABBVIE INC. | 15 | $220 |
| Otsuka America Pharmaceutical, Inc. | 11 | $183 |
| E.R. Squibb & Sons, L.L.C. | 8 | $152 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $78 |
| Corium, LLC | 5 | $76 |
| Neurocrine BioSciences, Inc. | 2 | $47 |
| Indivior Inc. | 1 | $36 |
Products named: ARISTADA, SPRAVATO, VRAYLAR, AUSTEDO XR, COBENFY, LYBALVI, REXULTI, ABILIFY ASIMTUFII.
Industry payments across NC — which companies pay providers there.
